The Investigators Are Comparing Lidocaine and Papaverine Nerve Blocks to Determine Which Improves Blood Flow Better, Making the "Phoenix Sign" Clearer on Imaging. This Helps Accurately Diagnose Nerve Compression, Improving Patient Care
Clinical trial NCT06919289 · COMPLETED
Trial details
- NCT number
- NCT06919289
- Sponsor
- US Neuropathy Centers
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-07
- Primary completion
- 2024-03-07
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.